Cargando…
The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial
BACKGROUND: Vitamin D deficiency has been shown to be closely associated with peritoneal dialysis (PD)-related peritonitis. The aim of this study is to examine the feasibility of conducting a large, powered randomized controlled trial to determine the effects of vitamin D supplementation on the risk...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883549/ https://www.ncbi.nlm.nih.gov/pubmed/31779675 http://dx.doi.org/10.1186/s13063-019-3784-7 |
_version_ | 1783474398118805504 |
---|---|
author | Zhang, Yu-hui Xu, Xiao Pi, Hai-chen Yang, Zhi-kai Johnson, David W. Dong, Jie |
author_facet | Zhang, Yu-hui Xu, Xiao Pi, Hai-chen Yang, Zhi-kai Johnson, David W. Dong, Jie |
author_sort | Zhang, Yu-hui |
collection | PubMed |
description | BACKGROUND: Vitamin D deficiency has been shown to be closely associated with peritoneal dialysis (PD)-related peritonitis. The aim of this study is to examine the feasibility of conducting a large, powered randomized controlled trial to determine the effects of vitamin D supplementation on the risk of PD-related peritonitis in patients who have already experienced an episode of peritonitis. METHODS: This prospective, open-label randomized controlled pilot trial with blinded end-points aims to determine the feasibility of oral vitamin D supplementation and to explore its effects on the risk of subsequent PD-related peritonitis among PD patients who have recovered from a recent episode of peritonitis. Eligible patients will be randomized 1:1 to either oral vitamin D supplementation (2000 IU per day; intervention group) or no vitamin D supplementation (control group) in addition to usual care according to International Society for Peritoneal Dialysis guidelines. The sample size will be 30 patients for both groups. All participants will be followed for 12 months. The primary outcome is the assessment of feasibility (recruitment success, retention, adherence, safety) and fidelity (change in serum 25-hydroxyvitamin D level during follow-up) for a large, powered randomized controlled trial to determine the effects of vitamin D on the risk of PD-related peritonitis in the future. Secondary outcomes include time to peritonitis occurrence, recovery of peritonitis, peritonitis-related transition to hemodialysis, and peritonitis-related death (defined as death within 30 days of peritonitis onset). DISCUSSION: This is the first randomized controlled trail investigating the effects of vitamin D supplementation on the risk of subsequent PD-related peritonitis among patients on PD. The findings for this pilot study will determine the feasibility of conducting a full-scale randomized controlled trail, which may provide a new strategy for preventing PD-related peritonitis among PD patients. TRIAL REGISTRATION: Clinicaltrails.gov, NCT03264625. Registered on 29 August 2017. |
format | Online Article Text |
id | pubmed-6883549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68835492019-12-03 The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial Zhang, Yu-hui Xu, Xiao Pi, Hai-chen Yang, Zhi-kai Johnson, David W. Dong, Jie Trials Study Protocol BACKGROUND: Vitamin D deficiency has been shown to be closely associated with peritoneal dialysis (PD)-related peritonitis. The aim of this study is to examine the feasibility of conducting a large, powered randomized controlled trial to determine the effects of vitamin D supplementation on the risk of PD-related peritonitis in patients who have already experienced an episode of peritonitis. METHODS: This prospective, open-label randomized controlled pilot trial with blinded end-points aims to determine the feasibility of oral vitamin D supplementation and to explore its effects on the risk of subsequent PD-related peritonitis among PD patients who have recovered from a recent episode of peritonitis. Eligible patients will be randomized 1:1 to either oral vitamin D supplementation (2000 IU per day; intervention group) or no vitamin D supplementation (control group) in addition to usual care according to International Society for Peritoneal Dialysis guidelines. The sample size will be 30 patients for both groups. All participants will be followed for 12 months. The primary outcome is the assessment of feasibility (recruitment success, retention, adherence, safety) and fidelity (change in serum 25-hydroxyvitamin D level during follow-up) for a large, powered randomized controlled trial to determine the effects of vitamin D on the risk of PD-related peritonitis in the future. Secondary outcomes include time to peritonitis occurrence, recovery of peritonitis, peritonitis-related transition to hemodialysis, and peritonitis-related death (defined as death within 30 days of peritonitis onset). DISCUSSION: This is the first randomized controlled trail investigating the effects of vitamin D supplementation on the risk of subsequent PD-related peritonitis among patients on PD. The findings for this pilot study will determine the feasibility of conducting a full-scale randomized controlled trail, which may provide a new strategy for preventing PD-related peritonitis among PD patients. TRIAL REGISTRATION: Clinicaltrails.gov, NCT03264625. Registered on 29 August 2017. BioMed Central 2019-11-28 /pmc/articles/PMC6883549/ /pubmed/31779675 http://dx.doi.org/10.1186/s13063-019-3784-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Zhang, Yu-hui Xu, Xiao Pi, Hai-chen Yang, Zhi-kai Johnson, David W. Dong, Jie The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial |
title | The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial |
title_full | The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial |
title_fullStr | The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial |
title_full_unstemmed | The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial |
title_short | The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial |
title_sort | effects of oral vitamin d supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883549/ https://www.ncbi.nlm.nih.gov/pubmed/31779675 http://dx.doi.org/10.1186/s13063-019-3784-7 |
work_keys_str_mv | AT zhangyuhui theeffectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT xuxiao theeffectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT pihaichen theeffectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT yangzhikai theeffectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT johnsondavidw theeffectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT dongjie theeffectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT zhangyuhui effectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT xuxiao effectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT pihaichen effectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT yangzhikai effectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT johnsondavidw effectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial AT dongjie effectsoforalvitamindsupplementationonthepreventionofperitonealdialysisrelatedperitonitisstudyprotocolforarandomizedcontrolledclinicaltrial |